SGI-1776 : The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells
Defactinib :G9a Promotes Invasion and Metastasis of Non-Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway
Metformin : Metformin in tuberculosis: beyond control of hyperglycemia
Penicillin-Streptomycin :Influence of microRNA‑34a on proliferation, invasion and metastasis of HCT116 cells
Tivantinib: A Phase II Study of the c-Met Inhibitor Tivantinib in Combination with FOLFOX for the Treatment of Patients with Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction, or Stomach
LDN-212854 : Strategic Targeting of Multiple BMP Receptors Prevents Trauma-Induced Heterotopic Ossification
Sitravatinib : SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancer